Search Results 81-90 of 15044 for Hepatitis C
To determine the prevalence of MBL in patients with chronic hepatitis C who are to begin therapy with DAA, and compare with clinic controls who are seen in the ...
On Mayo Clinic Radio, infectious diseases specialist Dr. Stacey Rizza outlines the risk factors for contracting hepatitis C, especially for people born between ...
The purpose of this study is to find the rate of Hepatitis B, Hepatitis C, and Hepatocellular Carcinoma in individual populations of African descendants living ...
A Study To Evaluate The Safety And Efficacy Of Ombitasvir/ABT-450/Ritonavir And Dasabuvir In Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection ...
Develop advanced imaging technology for monitoring liver inflammation during direct-acting antiviral treatment for hepatitis C, and evaluate risks of severe ...
Both drugs are FDA-approved. Mavyret™ is currently used commercially to treat Hepatitis C and Zetia® is used commercially to treat high cholesterol.
one of several hepatitis viruses, is generally considered to be the most serious. Left untreated, hepatitis C can cause serious liver damage, cirrhosis and even ...
A Study Comparing Measurements of Response to Antiviral Treatments for Liver Transplant Patients that have Recurrent Hepatitis C · More about research at Mayo ...
For most organ transplant recipients, receiving the “gift of life” is a one-time experience. But for Nellie Betancourt, battling the hepatitis C virus that had ...
People with chronic liver disease, including hepatitis B or hepatitis C; Anyone wishing to obtain protection (immunity). If you're concerned about your risk ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.